IL6 and chronic kidney disease: In the main analysis, there was no strong evidence for an association of genetically proxied inhibition of IL‐6 inhibition with log eGFR (0.001, 95% confidence interval −0.004‐0.007), BUN (0.009, 95% confidence interval −0.003‐0.021) and CKD (odds ratio 0.948, 95% confidence interval 0.822‐1.094).